SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-058267
Filing Date
2018-02-26
Accepted
2018-02-26 14:35:04
Documents
3
Period of Report
2018-02-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d467077d8k.htm 8-K 17215
2 EX-99.1 d467077dex991.htm EX-99.1 7822
3 GRAPHIC g467077g0224041722756.jpg GRAPHIC 2508
  Complete submission text file 0001193125-18-058267.txt   30018
Mailing Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTER DRIVE SUITE 500 SAN DIEGO CA 92130 858-792-6300
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 000-50484 | Film No.: 18640041
SIC: 2834 Pharmaceutical Preparations